Anxiety and depression in patients with confirmed and suspected COVID-19 in Ecuador

dc.contributor.authorPaz, Clara
dc.contributor.authorMascialino, Guido
dc.contributor.authorAdana Díaz, Lila
dc.contributor.authorRodríguez Lorenzana, Alberto
dc.contributor.authorSimbaña-Rivera, Katherine
dc.contributor.authorGómez-Barreno, Lenin
dc.contributor.authorTroya, Maritza
dc.contributor.authorPáez, María Ignacia
dc.contributor.authorCárdenas, Javier
dc.contributor.authorGerstner, Rebekka M.
dc.contributor.authorOrtiz-Prado, Esteban
dc.contributor.departmentCiencias de la Saludes_ES
dc.contributor.departmentOsasun Zientziakeu
dc.date.accessioned2024-02-06T15:52:38Z
dc.date.available2024-02-06T15:52:38Z
dc.date.issued2020
dc.date.updated2024-02-06T15:27:44Z
dc.description.abstractThe rapid spread of the novel coronavirus, SARS-CoV-2 throughout the world has forced local and national administrations to take unprecedented measures to reduce the impact of the coronavirus diseases (COVID-19) pandemic. In South America, the arrival of the virus took longer than in other regions of the world, nevertheless, the impact has already been unprecedent. For instance, Ecuador was one of the most affected countries by the pandemic, reported hundreds of deaths each day during the last weeks of March and the first weeks of April 2020. The mortality rates were high during these months due to late implementation of restrictive measures of social distancing and limited capacity of health services (testing capacities and contact tracing). In this scenario, the Ecuadorian Ministry of Public Health (MoPH) established an epidemiological surveillance program for COVID-19 confirmed and suspected patients. The Department of Mental Health at the MoPH in Ecuador lead an active surveillance of the emotional impact of the disease by deploying an online self-reporting tool among patients to identify needs and provide standard of care treatment. The authors of this study were asked to participate in the development of this survey. The tool recorded sociodemographic variables and responses from two questionnaires: the Patient Health Questionnaire (PHQ-9) to measure the presence and severity of depressive symptoms, and the Generalized Anxiety Disorder (GAD-7) to assess the presence and severity of anxiety symptoms.en
dc.description.sponsorshipThe project was funded by the Dirección General de Investigación, Universidad de Las Américas, Quito, Ecuador.en
dc.format.mimetypeapplication/pdfen
dc.identifier.citationPaz, C., Mascialino, G., Adana-Díaz, L., Rodríguez-Lorenzana, A., Simbaña-Rivera, K., Gómez-Barreno, L., Troya, M., Páez, M. I., Cárdenas, J., Gerstner, R. M., Ortiz-Prado, E. (2020) Anxiety and depression in patients with confirmed and suspected COVID-19 in Ecuador. Psychiatry and Clinical Neurosciences, 74(10), 554-555. https://doi.org/10.1111/pcn.13106.en
dc.identifier.doi10.1111/pcn.13106
dc.identifier.issn1323-1316
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/47354
dc.language.isoengen
dc.publisherWileyen
dc.relation.ispartofPsychiatry and Clinical Neurosciences 2020, 74(10), 554–555en
dc.relation.publisherversionhttps://doi.org/10.1111/pcn.13106
dc.rights©2020 The Authors. Psychiatry and Clinical Neurosciences ©2020 Japanese Society of Psychiatry and Neurology.en
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subjectCOVID-19en
dc.subjectEcuadoren
dc.subjectPatientsen
dc.subjectAnxietyen
dc.subjectDepressionen
dc.titleAnxiety and depression in patients with confirmed and suspected COVID-19 in Ecuadoren
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dspace.entity.typePublication
relation.isAuthorOfPublication5d4af467-7d54-453e-94d0-d39d7c76369a
relation.isAuthorOfPublication.latestForDiscovery5d4af467-7d54-453e-94d0-d39d7c76369a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Paz_AnxietyDepresion.pdf
Size:
261.77 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.78 KB
Format:
Item-specific license agreed to upon submission
Description: